The Temozolomide-Doxorubicin paradox in Glioblastoma in vitro-in silico preclinical drug-screening.
Oraiopoulou ME, Tzamali E, Psycharakis SE, Tzedakis G, Makatounakis T, Manolitsi K, Drakos E, Vakis AF, Zacharakis G, Papamatheakis J, Sakkalis V.
Oraiopoulou ME, et al. Among authors: psycharakis se.
Sci Rep. 2024 Feb 14;14(1):3759. doi: 10.1038/s41598-024-53684-y.
Sci Rep. 2024.
PMID: 38355655
Free PMC article.